Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
29.69
-0.29 (-0.97%)
At close: Feb 27, 2026, 4:00 PM EST
29.75
+0.06 (0.20%)
After-hours: Feb 27, 2026, 7:43 PM EST
Alumis Market Cap
Alumis has a market cap or net worth of $3.7 billion as of February 27, 2026. Its market cap has increased by 1,252.38% in one year.
Market Cap
3.70B
Enterprise Value
3.36B
1-Year Change
1,252.38%
Ranking
Category
Stock Price
$29.69
Market Cap Chart
Since the IPO on June 28, 2024, Alumis's market cap has increased from $901.92M to $3.70B, an increase of 310.35%. That is a compound annual growth rate of 133.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 3.70B | 263.25% |
| Dec 31, 2025 | 1.02B | 138.26% |
| Dec 31, 2024 | 427.64M | -52.59% |
| Jun 28, 2024 | 901.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NewAmsterdam Pharma Company | 4.08B |
| Ligand Pharmaceuticals | 3.95B |
| Centessa Pharmaceuticals | 3.92B |
| Viking Therapeutics | 3.91B |
| Corcept Therapeutics | 3.80B |
| ADMA Biologics | 3.71B |
| Xenon Pharmaceuticals | 3.60B |
| Legend Biotech | 3.51B |